4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride

C20H26BrCl4N5S — CID 68902280

IUPAC4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride
SMILESCN1CCN(CCCNc2ncc(Cl)c(-c3cc4ccc(Br)cc4s3)n2)CC1.Cl.Cl.Cl
InChIInChI=1S/C20H23BrClN5S.3ClH/c1-26-7-9-27(10-8-26)6-2-5-23-20-24-13-16(22)19(25-20)18-11-14-3-4-15(21)12-17(14)28-18;;;/h3-4,11-13H,2,5-10H2,1H3,(H,23,24,25);3*1H
InChIKeyUVPIEVLXDUYOGV-UHFFFAOYSA-N
MW590.25 g/mol
LogP6.09
Rot. Bonds6

About 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride

4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride (PubChem CID 68902280) has the molecular formula C20H26BrCl4N5S and a molecular weight of 590.25 g/mol. Its IUPAC name is 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride.

Molecular Properties

Compound Name4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride
PubChem CID68902280
Molecular FormulaC20H26BrCl4N5S
Molecular Weight590.25 g/mol
Exact Mass586.98
IUPAC Name4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride
SMILESCN1CCN(CCCNc2ncc(Cl)c(-c3cc4ccc(Br)cc4s3)n2)CC1.Cl.Cl.Cl
InChIInChI=1S/C20H23BrClN5S.3ClH/c1-26-7-9-27(10-8-26)6-2-5-23-20-24-13-16(22)19(25-20)18-11-14-3-4-15(21)12-17(14)28-18;;;/h3-4,11-13H,2,5-10H2,1H3,(H,23,24,25);3*1H
InChIKeyUVPIEVLXDUYOGV-UHFFFAOYSA-N
XLogP6.09
TPSA44.29 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500590.25
LogP ≤ 56.09
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride?
The IUPAC name of 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride (CID 68902280) is 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride.
What is the SMILES notation for 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride?
The canonical SMILES for 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride is CN1CCN(CCCNc2ncc(Cl)c(-c3cc4ccc(Br)cc4s3)n2)CC1.Cl.Cl.Cl.
What is the InChIKey of 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride?
The InChIKey is UVPIEVLXDUYOGV-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23BrClN5S.3ClH/c1-26-7-9-27(10-8-26)6-2-5-23-20-24-13-16(22)19(25-20)18-11-14-3-4-15(21)12-17(14)28-18;;;/h3-4,11-13H,2,5-10H2,1H3,(H,23,24,25);3*1H.
What are the key properties of 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride?
4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride has a molecular weight of 590.25 g/mol, XLogP of 6.09, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine;trihydrochloride is sourced from PubChem (CID 68902280), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).